The global Preformulation CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Preformulation CDMO Service refers to a one-stop R&D and manufacturing service provided to clients in the early stages of drug formulation development, from active ingredient (API) characterization to preliminary formulation design. Its core lies in the systematic evaluation of the API's physicochemical properties, stability, and compatibility to screen suitable excipients and dosage forms, developing stable and feasible laboratory-grade formulation prototypes (such as premixes, granules, or simple dosage forms). This stage of service lays the scientific foundation for subsequent formal formulation process development, clinical sample production, and commercial scale-up, significantly reducing R&D risks and accelerating project progress, especially suitable for the early development of innovative drugs or complex formulations. Preformulation CDMOs integrate pharmaceutical science knowledge, analytical techniques, and early manufacturing capabilities, serving as a crucial bridge between drug discovery and clinical development.

The costs of Preformation CDMO Service primarily consist of highly qualified R&D personnel, depreciation of high-end analytical instruments, and consumption of APIs and special auxiliary materials, with fixed costs accounting for a relatively high proportion. Their gross profit margin is typically significantly higher than that of traditional large-scale production processes, generally reaching 40%-60%. This high gross profit margin stems from their technology-intensive and project-customized nature; their core value lies in mitigating early-stage R&D risks for clients, resulting in a significant premium for knowledge output.

The global development of Preformulation CDMO Service exhibits distinct regional differences and cluster effects. North America (especially the United States) is the largest market and source of innovation, dominated by numerous small and medium-sized CDMOs and large conglomerates focused on early-stage development and cutting-edge technologies, with demand primarily coming from active biotech companies. Europe possesses a strong pharmaceutical foundation, leading in technology in niche areas such as complex formulations and highly active drugs, and its market is mature and strictly regulated. Asia is the most dynamic growth engine, with the Chinese market expanding rapidly driven by the wave of innovative drug development, cost advantages, and government support, transitioning from "follower" to "technology upgrader"; India, on the other hand, is competitive in cost control and generic drug co-development. The overall landscape is characterized by technology leadership from Europe and the United States, growth driven by the Asia-Pacific region, and increasingly close collaboration across the global supply chain.

This report delivers a comprehensive overview of the global Preformulation CDMO Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Preformulation CDMO Service. The Preformulation CDMO Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Preformulation CDMO Service market comprehensively. Regional market sizes by Type, by Application, by Formulation Technology, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Preformulation CDMO Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Preformulation CDMO Service Market Report

Report Metric	Details
Report Name	Preformulation CDMO Service Market
Segment by Type	Basic Characteristics CDMO Service Pre-formulation Research CDMO Service Prototype Formulation Development CDMO Service
Segment by Formulation Technology	Oral Formulation CDMO Service Complex Injectable Formulation CDMO Service Novel Drug Delivery System CDMO Service
Segment by Service Model	Discrete Service End-to-End Service
Segment by Application	Innovative Drug Development Improved New Drug Development Generic and Biosimilar Drug Development Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aenova, Ascendia Pharmaceutical, Aurigene Pharmaceutical Services, Corealis Pharma, CritiTech, Crystal Pharmatech, DPT Laboratories, Eirgen Pharma, Eurofins Scientific, Koziatek Consulting, Lonza, Oakwood Labs, Quotient Sciences, Sofpromed, Upperton Pharma Solutions, American Pharmaceutical Review, Bluepharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Formulation Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Preformulation CDMO Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Preformulation CDMO Service Market report?

Ans: The main players in the Preformulation CDMO Service Market are Aenova, Ascendia Pharmaceutical, Aurigene Pharmaceutical Services, Corealis Pharma, CritiTech, Crystal Pharmatech, DPT Laboratories, Eirgen Pharma, Eurofins Scientific, Koziatek Consulting, Lonza, Oakwood Labs, Quotient Sciences, Sofpromed, Upperton Pharma Solutions, American Pharmaceutical Review, Bluepharma

What are the Application segmentation covered in the Preformulation CDMO Service Market report?

Ans: The Applications covered in the Preformulation CDMO Service Market report are Innovative Drug Development, Improved New Drug Development, Generic and Biosimilar Drug Development, Others

What are the Type segmentation covered in the Preformulation CDMO Service Market report?

Ans: The Types covered in the Preformulation CDMO Service Market report are Basic Characteristics CDMO Service, Pre-formulation Research CDMO Service, Prototype Formulation Development CDMO Service

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Preformulation CDMO Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Basic Characteristics CDMO Service

1.2.3 Pre-formulation Research CDMO Service

1.2.4 Prototype Formulation Development CDMO Service

1.3 Market by Formulation Technology

1.3.1 Global Preformulation CDMO Service Market Size Growth Rate by Formulation Technology: 2021 vs 2025 vs 2032

1.3.2 Oral Formulation CDMO Service

1.3.3 Complex Injectable Formulation CDMO Service

1.3.4 Novel Drug Delivery System CDMO Service

1.4 Market by Service Model

1.4.1 Global Preformulation CDMO Service Market Size Growth Rate by Service Model: 2021 vs 2025 vs 2032

1.4.2 Discrete Service

1.4.3 End-to-End Service

1.5 Market by Application

1.5.1 Global Preformulation CDMO Service Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Innovative Drug Development

1.5.3 Improved New Drug Development

1.5.4 Generic and Biosimilar Drug Development

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Preformulation CDMO Service Market Perspective (2021–2032)

2.2 Global Preformulation CDMO Service Growth Trends by Region

2.2.1 Global Preformulation CDMO Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Preformulation CDMO Service Historic Market Size by Region (2021–2026)

2.2.3 Preformulation CDMO Service Forecasted Market Size by Region (2027–2032)

2.3 Preformulation CDMO Service Market Dynamics

2.3.1 Preformulation CDMO Service Industry Trends

2.3.2 Preformulation CDMO Service Market Drivers

2.3.3 Preformulation CDMO Service Market Challenges

2.3.4 Preformulation CDMO Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Preformulation CDMO Service Players by Revenue

3.1.1 Global Top Preformulation CDMO Service Players by Revenue (2021–2026)

3.1.2 Global Preformulation CDMO Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Preformulation CDMO Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Preformulation CDMO Service Revenue

3.4 Global Preformulation CDMO Service Market Concentration Ratio

3.4.1 Global Preformulation CDMO Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Preformulation CDMO Service Revenue in 2025

3.5 Global Key Players of Preformulation CDMO Service Head Offices and Areas Served

3.6 Global Key Players of Preformulation CDMO Service, Products and Applications

3.7 Global Key Players of Preformulation CDMO Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Preformulation CDMO Service Breakdown Data by Type

4.1 Global Preformulation CDMO Service Historic Market Size by Type (2021–2026)

4.2 Global Preformulation CDMO Service Forecasted Market Size by Type (2027–2032)

5 Preformulation CDMO Service Breakdown Data by Application

5.1 Global Preformulation CDMO Service Historic Market Size by Application (2021–2026)

5.2 Global Preformulation CDMO Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Preformulation CDMO Service Market Size (2021–2032)

6.2 North America Preformulation CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Preformulation CDMO Service Market Size by Country (2021–2026)

6.4 North America Preformulation CDMO Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Preformulation CDMO Service Market Size (2021–2032)

7.2 Europe Preformulation CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Preformulation CDMO Service Market Size by Country (2021–2026)

7.4 Europe Preformulation CDMO Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Preformulation CDMO Service Market Size (2021–2032)

8.2 Asia-Pacific Preformulation CDMO Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Preformulation CDMO Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Preformulation CDMO Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Preformulation CDMO Service Market Size (2021–2032)

9.2 Latin America Preformulation CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Preformulation CDMO Service Market Size by Country (2021–2026)

9.4 Latin America Preformulation CDMO Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Preformulation CDMO Service Market Size (2021–2032)

10.2 Middle East & Africa Preformulation CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Preformulation CDMO Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Preformulation CDMO Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Aenova

11.1.1 Aenova Company Details

11.1.2 Aenova Business Overview

11.1.3 Aenova Preformulation CDMO Service Introduction

11.1.4 Aenova Revenue in Preformulation CDMO Service Business (2021–2026)

11.1.5 Aenova Recent Development

11.2 Ascendia Pharmaceutical

11.2.1 Ascendia Pharmaceutical Company Details

11.2.2 Ascendia Pharmaceutical Business Overview

11.2.3 Ascendia Pharmaceutical Preformulation CDMO Service Introduction

11.2.4 Ascendia Pharmaceutical Revenue in Preformulation CDMO Service Business (2021–2026)

11.2.5 Ascendia Pharmaceutical Recent Development

11.3 Aurigene Pharmaceutical Services

11.3.1 Aurigene Pharmaceutical Services Company Details

11.3.2 Aurigene Pharmaceutical Services Business Overview

11.3.3 Aurigene Pharmaceutical Services Preformulation CDMO Service Introduction

11.3.4 Aurigene Pharmaceutical Services Revenue in Preformulation CDMO Service Business (2021–2026)

11.3.5 Aurigene Pharmaceutical Services Recent Development

11.4 Corealis Pharma

11.4.1 Corealis Pharma Company Details

11.4.2 Corealis Pharma Business Overview

11.4.3 Corealis Pharma Preformulation CDMO Service Introduction

11.4.4 Corealis Pharma Revenue in Preformulation CDMO Service Business (2021–2026)

11.4.5 Corealis Pharma Recent Development

11.5 CritiTech

11.5.1 CritiTech Company Details

11.5.2 CritiTech Business Overview

11.5.3 CritiTech Preformulation CDMO Service Introduction

11.5.4 CritiTech Revenue in Preformulation CDMO Service Business (2021–2026)

11.5.5 CritiTech Recent Development

11.6 Crystal Pharmatech

11.6.1 Crystal Pharmatech Company Details

11.6.2 Crystal Pharmatech Business Overview

11.6.3 Crystal Pharmatech Preformulation CDMO Service Introduction

11.6.4 Crystal Pharmatech Revenue in Preformulation CDMO Service Business (2021–2026)

11.6.5 Crystal Pharmatech Recent Development

11.7 DPT Laboratories

11.7.1 DPT Laboratories Company Details

11.7.2 DPT Laboratories Business Overview

11.7.3 DPT Laboratories Preformulation CDMO Service Introduction

11.7.4 DPT Laboratories Revenue in Preformulation CDMO Service Business (2021–2026)

11.7.5 DPT Laboratories Recent Development

11.8 Eirgen Pharma

11.8.1 Eirgen Pharma Company Details

11.8.2 Eirgen Pharma Business Overview

11.8.3 Eirgen Pharma Preformulation CDMO Service Introduction

11.8.4 Eirgen Pharma Revenue in Preformulation CDMO Service Business (2021–2026)

11.8.5 Eirgen Pharma Recent Development

11.9 Eurofins Scientific

11.9.1 Eurofins Scientific Company Details

11.9.2 Eurofins Scientific Business Overview

11.9.3 Eurofins Scientific Preformulation CDMO Service Introduction

11.9.4 Eurofins Scientific Revenue in Preformulation CDMO Service Business (2021–2026)

11.9.5 Eurofins Scientific Recent Development

11.10 Koziatek Consulting

11.10.1 Koziatek Consulting Company Details

11.10.2 Koziatek Consulting Business Overview

11.10.3 Koziatek Consulting Preformulation CDMO Service Introduction

11.10.4 Koziatek Consulting Revenue in Preformulation CDMO Service Business (2021–2026)

11.10.5 Koziatek Consulting Recent Development

11.11 Lonza

11.11.1 Lonza Company Details

11.11.2 Lonza Business Overview

11.11.3 Lonza Preformulation CDMO Service Introduction

11.11.4 Lonza Revenue in Preformulation CDMO Service Business (2021–2026)

11.11.5 Lonza Recent Development

11.12 Oakwood Labs

11.12.1 Oakwood Labs Company Details

11.12.2 Oakwood Labs Business Overview

11.12.3 Oakwood Labs Preformulation CDMO Service Introduction

11.12.4 Oakwood Labs Revenue in Preformulation CDMO Service Business (2021–2026)

11.12.5 Oakwood Labs Recent Development

11.13 Quotient Sciences

11.13.1 Quotient Sciences Company Details

11.13.2 Quotient Sciences Business Overview

11.13.3 Quotient Sciences Preformulation CDMO Service Introduction

11.13.4 Quotient Sciences Revenue in Preformulation CDMO Service Business (2021–2026)

11.13.5 Quotient Sciences Recent Development

11.14 Sofpromed

11.14.1 Sofpromed Company Details

11.14.2 Sofpromed Business Overview

11.14.3 Sofpromed Preformulation CDMO Service Introduction

11.14.4 Sofpromed Revenue in Preformulation CDMO Service Business (2021–2026)

11.14.5 Sofpromed Recent Development

11.15 Upperton Pharma Solutions

11.15.1 Upperton Pharma Solutions Company Details

11.15.2 Upperton Pharma Solutions Business Overview

11.15.3 Upperton Pharma Solutions Preformulation CDMO Service Introduction

11.15.4 Upperton Pharma Solutions Revenue in Preformulation CDMO Service Business (2021–2026)

11.15.5 Upperton Pharma Solutions Recent Development

11.16 American Pharmaceutical Review

11.16.1 American Pharmaceutical Review Company Details

11.16.2 American Pharmaceutical Review Business Overview

11.16.3 American Pharmaceutical Review Preformulation CDMO Service Introduction

11.16.4 American Pharmaceutical Review Revenue in Preformulation CDMO Service Business (2021–2026)

11.16.5 American Pharmaceutical Review Recent Development

11.17 Bluepharma

11.17.1 Bluepharma Company Details

11.17.2 Bluepharma Business Overview

11.17.3 Bluepharma Preformulation CDMO Service Introduction

11.17.4 Bluepharma Revenue in Preformulation CDMO Service Business (2021–2026)

11.17.5 Bluepharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Foundation

Aenova

Aurigene Pharmaceutical Services

Upperton Pharma Solutions

American Pharmaceutical Review

Bluepharma

Ascendia Pharmaceutical

Koziatek Consulting

List of Tables

Table 1. Global Preformulation CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Basic Characteristics CDMO Service

Table 3. Key Players of Pre-formulation Research CDMO Service

Table 4. Key Players of Prototype Formulation Development CDMO Service

Table 5. Global Preformulation CDMO Service Market Size Growth Rate by Formulation Technology (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of Oral Formulation CDMO Service

Table 7. Key Players of Complex Injectable Formulation CDMO Service

Table 8. Key Players of Novel Drug Delivery System CDMO Service

Table 9. Global Preformulation CDMO Service Market Size Growth Rate by Service Model (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Discrete Service

Table 11. Key Players of End-to-End Service

Table 12. Global Preformulation CDMO Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 13. Global Preformulation CDMO Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global Preformulation CDMO Service Market Size by Region (US$ Million), 2021–2026

Table 15. Global Preformulation CDMO Service Market Share by Region (2021–2026)

Table 16. Global Preformulation CDMO Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 17. Global Preformulation CDMO Service Market Share by Region (2027–2032)

Table 18. Preformulation CDMO Service Market Trends

Table 19. Preformulation CDMO Service Market Drivers

Table 20. Preformulation CDMO Service Market Challenges

Table 21. Preformulation CDMO Service Market Restraints

Table 22. Global Preformulation CDMO Service Revenue by Players (US$ Million), 2021–2026

Table 23. Global Preformulation CDMO Service Market Share by Players (2021–2026)

Table 24. Global Top Preformulation CDMO Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Preformulation CDMO Service Revenue, 2025

Table 25. Ranking of Global Top Preformulation CDMO Service Companies by Revenue (US$ Million) in 2025

Table 26. Global 5 Largest Players Market Share by Preformulation CDMO Service Revenue (CR5 and HHI), 2021–2026

Table 27. Global Key Players of Preformulation CDMO Service, Headquarters and Area Served

Table 28. Global Key Players of Preformulation CDMO Service, Products and Applications

Table 29. Global Key Players of Preformulation CDMO Service, Date of General Availability (GA)

Table 30. Mergers and Acquisitions, Expansion Plans

Table 31. Global Preformulation CDMO Service Market Size by Type (US$ Million), 2021–2026

Table 32. Global Preformulation CDMO Service Revenue Market Share by Type (2021–2026)

Table 33. Global Preformulation CDMO Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 34. Global Preformulation CDMO Service Revenue Market Share by Type (2027–2032)

Table 35. Global Preformulation CDMO Service Market Size by Application (US$ Million), 2021–2026

Table 36. Global Preformulation CDMO Service Revenue Market Share by Application (2021–2026)

Table 37. Global Preformulation CDMO Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 38. Global Preformulation CDMO Service Revenue Market Share by Application (2027–2032)

Table 39. North America Preformulation CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. North America Preformulation CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 41. North America Preformulation CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 42. Europe Preformulation CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Europe Preformulation CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 44. Europe Preformulation CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 45. Asia-Pacific Preformulation CDMO Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 46. Asia-Pacific Preformulation CDMO Service Market Size by Region (US$ Million), 2021–2026

Table 47. Asia-Pacific Preformulation CDMO Service Market Size by Region (US$ Million), 2027–2032

Table 48. Latin America Preformulation CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Latin America Preformulation CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 50. Latin America Preformulation CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 51. Middle East & Africa Preformulation CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Middle East & Africa Preformulation CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 53. Middle East & Africa Preformulation CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 54. Aenova Company Details

Table 55. Aenova Business Overview

Table 56. Aenova Preformulation CDMO Service Product

Table 57. Aenova Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 58. Aenova Recent Development

Table 59. Ascendia Pharmaceutical Company Details

Table 60. Ascendia Pharmaceutical Business Overview

Table 61. Ascendia Pharmaceutical Preformulation CDMO Service Product

Table 62. Ascendia Pharmaceutical Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 63. Ascendia Pharmaceutical Recent Development

Table 64. Aurigene Pharmaceutical Services Company Details

Table 65. Aurigene Pharmaceutical Services Business Overview

Table 66. Aurigene Pharmaceutical Services Preformulation CDMO Service Product

Table 67. Aurigene Pharmaceutical Services Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 68. Aurigene Pharmaceutical Services Recent Development

Table 69. Corealis Pharma Company Details

Table 70. Corealis Pharma Business Overview

Table 71. Corealis Pharma Preformulation CDMO Service Product

Table 72. Corealis Pharma Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 73. Corealis Pharma Recent Development

Table 74. CritiTech Company Details

Table 75. CritiTech Business Overview

Table 76. CritiTech Preformulation CDMO Service Product

Table 77. CritiTech Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 78. CritiTech Recent Development

Table 79. Crystal Pharmatech Company Details

Table 80. Crystal Pharmatech Business Overview

Table 81. Crystal Pharmatech Preformulation CDMO Service Product

Table 82. Crystal Pharmatech Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 83. Crystal Pharmatech Recent Development

Table 84. DPT Laboratories Company Details

Table 85. DPT Laboratories Business Overview

Table 86. DPT Laboratories Preformulation CDMO Service Product

Table 87. DPT Laboratories Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 88. DPT Laboratories Recent Development

Table 89. Eirgen Pharma Company Details

Table 90. Eirgen Pharma Business Overview

Table 91. Eirgen Pharma Preformulation CDMO Service Product

Table 92. Eirgen Pharma Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 93. Eirgen Pharma Recent Development

Table 94. Eurofins Scientific Company Details

Table 95. Eurofins Scientific Business Overview

Table 96. Eurofins Scientific Preformulation CDMO Service Product

Table 97. Eurofins Scientific Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 98. Eurofins Scientific Recent Development

Table 99. Koziatek Consulting Company Details

Table 100. Koziatek Consulting Business Overview

Table 101. Koziatek Consulting Preformulation CDMO Service Product

Table 102. Koziatek Consulting Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 103. Koziatek Consulting Recent Development

Table 104. Lonza Company Details

Table 105. Lonza Business Overview

Table 106. Lonza Preformulation CDMO Service Product

Table 107. Lonza Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 108. Lonza Recent Development

Table 109. Oakwood Labs Company Details

Table 110. Oakwood Labs Business Overview

Table 111. Oakwood Labs Preformulation CDMO Service Product

Table 112. Oakwood Labs Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 113. Oakwood Labs Recent Development

Table 114. Quotient Sciences Company Details

Table 115. Quotient Sciences Business Overview

Table 116. Quotient Sciences Preformulation CDMO Service Product

Table 117. Quotient Sciences Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 118. Quotient Sciences Recent Development

Table 119. Sofpromed Company Details

Table 120. Sofpromed Business Overview

Table 121. Sofpromed Preformulation CDMO Service Product

Table 122. Sofpromed Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 123. Sofpromed Recent Development

Table 124. Upperton Pharma Solutions Company Details

Table 125. Upperton Pharma Solutions Business Overview

Table 126. Upperton Pharma Solutions Preformulation CDMO Service Product

Table 127. Upperton Pharma Solutions Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 128. Upperton Pharma Solutions Recent Development

Table 129. American Pharmaceutical Review Company Details

Table 130. American Pharmaceutical Review Business Overview

Table 131. American Pharmaceutical Review Preformulation CDMO Service Product

Table 132. American Pharmaceutical Review Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 133. American Pharmaceutical Review Recent Development

Table 134. Bluepharma Company Details

Table 135. Bluepharma Business Overview

Table 136. Bluepharma Preformulation CDMO Service Product

Table 137. Bluepharma Revenue in Preformulation CDMO Service Business (US$ Million), 2021–2026

Table 138. Bluepharma Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. Authors List of This Report

List of Figures

Figure 1. Preformulation CDMO Service Picture

Figure 2. Global Preformulation CDMO Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Preformulation CDMO Service Market Share by Type: 2025 vs 2032

Figure 4. Basic Characteristics CDMO Service Features

Figure 5. Pre-formulation Research CDMO Service Features

Figure 6. Prototype Formulation Development CDMO Service Features

Figure 7. Global Preformulation CDMO Service Market Size Comparison by Formulation Technology (US$ Million), 2021–2032

Figure 8. Oral Formulation CDMO Service Features

Figure 9. Complex Injectable Formulation CDMO Service Features

Figure 10. Novel Drug Delivery System CDMO Service Features

Figure 11. Global Preformulation CDMO Service Market Size Comparison by Service Model (US$ Million), 2021–2032

Figure 12. Discrete Service Features

Figure 13. End-to-End Service Features

Figure 14. Global Preformulation CDMO Service Market Size by Application (US$ Million), 2021–2032

Figure 15. Global Preformulation CDMO Service Market Share by Application: 2025 vs 2032

Figure 16. Innovative Drug Development Case Studies

Figure 17. Improved New Drug Development Case Studies

Figure 18. Generic and Biosimilar Drug Development Case Studies

Figure 19. Others Case Studies

Figure 20. Preformulation CDMO Service Report Years Considered

Figure 21. Global Preformulation CDMO Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global Preformulation CDMO Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Preformulation CDMO Service Market Share by Region: 2025 vs 2032

Figure 24. Global Preformulation CDMO Service Market Share by Players in 2025

Figure 25. Global Preformulation CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Preformulation CDMO Service Revenue in 2025

Figure 27. North America Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America Preformulation CDMO Service Market Share by Country (2021–2032)

Figure 29. United States Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe Preformulation CDMO Service Market Share by Country (2021–2032)

Figure 33. Germany Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific Preformulation CDMO Service Market Share by Region (2021–2032)

Figure 41. China Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America Preformulation CDMO Service Market Share by Country (2021–2032)

Figure 49. Mexico Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa Preformulation CDMO Service Market Share by Country (2021–2032)

Figure 53. Israel Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE Preformulation CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Aenova Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 57. Ascendia Pharmaceutical Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 58. Aurigene Pharmaceutical Services Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 59. Corealis Pharma Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 60. CritiTech Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 61. Crystal Pharmatech Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 62. DPT Laboratories Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 63. Eirgen Pharma Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 64. Eurofins Scientific Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 65. Koziatek Consulting Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 66. Lonza Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 67. Oakwood Labs Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 68. Quotient Sciences Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 69. Sofpromed Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 70. Upperton Pharma Solutions Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 71. American Pharmaceutical Review Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 72. Bluepharma Revenue Growth Rate in Preformulation CDMO Service Business (2021–2026)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions